MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MediWound Ltd (MDWD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9804
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’s first innovative biopharmaceutical product, NexoBrid is approved for removal of damaged or dead tissue, namely, eschar, in adults with deep partial and full-thickness thermal burns. MediWound has approval to market NexoBrid in the European Union, Israel and Argentina. The company sells NexoBrid in Europe, Israel through its commercial organization and in Argentina, through local distributor. MediWound is headquartered in Yavne, Israel.

MediWound Ltd (MDWD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9
MediWound Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MediWound Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
MediWound Raises US$20 Million In Venture Financing 11
Partnerships 12
MediWound Enters into Distribution Agreement with Holy Stone Healthcare 12
MediWound Enters Distribution Agreement with Avalon Pharma for NexoBrid 13
MediWound Enters Distribution Agreement With Genfa Medica For NexoBrid 14
Licensing Agreements 15
Kaken Pharma Enters into Licensing Agreement with MediWound 15
Equity Offering 16
MediWound Raises USD25.2 Million in Public Offering of Shares 16
MediWound Completes IPO For US$80.5 Million 18
Asset Transactions 20
MediWound to Sell NexoBrid 20
MediWound Ltd – Key Competitors 21
MediWound Ltd – Key Employees 22
MediWound Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 07, 2018: MediWound Reports Second Quarter 2018 Financial Results 24
May 10, 2018: MediWound Reports First Quarter 2018 Financial Results 26
Mar 19, 2018: MediWound Announces Fourth Quarter And Fiscal Year 2017 Financial Results 28
Nov 16, 2017: MediWound Reports Third Quarter 2017 Financial Results 31
Aug 03, 2017: MediWound Reports Second Quarter 2017 Financial Results 33
May 08, 2017: MediWound Reports First Quarter 2017 Financial Results 35
Feb 21, 2017: MediWound Reports 2016 Fourth Quarter and Full Year Financial Results 37
Corporate Communications 39
Oct 25, 2017: MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors 39
May 18, 2017: MediWound Announces Changes to its Board of Directors 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
MediWound Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9
MediWound Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MediWound Raises US$20 Million In Venture Financing 11
MediWound Enters into Distribution Agreement with Holy Stone Healthcare 12
MediWound Enters Distribution Agreement with Avalon Pharma for NexoBrid 13
MediWound Enters Distribution Agreement With Genfa Medica For NexoBrid 14
Kaken Pharma Enters into Licensing Agreement with MediWound 15
MediWound Raises USD25.2 Million in Public Offering of Shares 16
MediWound Completes IPO For US$80.5 Million 18
MediWound to Sell NexoBrid 20
MediWound Ltd, Key Competitors 21
MediWound Ltd, Key Employees 22
MediWound Ltd, Subsidiaries 23

List of Figures
MediWound Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Russian Aircraft Corporation MiG JSC:企業の戦略・SWOT・財務情報
    Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report Summary Russian Aircraft Corporation MiG JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Keppel Corp Ltd (BN4):石油・ガス:M&Aディール及び事業提携情報
    Summary Keppel Corp Ltd (Keppel) is an investment holding and management company. The Company, through its subsidiaries, carries out operation in the marine, property, infrastructure and telecommunications and transportation businesses. Keppel focuses on offshore oil-rig construction, repair and upg …
  • GeNeuro SA (GNRO):製薬・医療:M&Aディール及び事業提携情報
    Summary GeNeuro SA (GeNeuro) is a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develops therap …
  • Pernix Therapeutics Holdings Inc (PTX):医療機器:M&Aディール及び事業提携情報
    Summary Pernix Therapeutics Holdings Inc (Pernix Therapeutics) is a specialty pharmaceutical company that discovers, develops, and markets generic pharmaceutical products. The company’s portfolio encompasses a fixed dose combination product prescribed to treat acute migraine; an extended-release (XR …
  • Kurumoch International Airport:企業の戦略・SWOT・財務分析
    Kurumoch International Airport - Strategy, SWOT and Corporate Finance Report Summary Kurumoch International Airport - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Arabian Bemco Contracting Co. Ltd.
    Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arabian Bemco Contracting Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Flexsteel Industries Inc (FLXS):企業の財務・戦略的SWOT分析
    Flexsteel Industries Inc (FLXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly known as Arrowhead Research Corp, is a pharmaceutical company. It develops and markets medicinal products including ARO-AAT, JNJ-3989, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, ARO-Lung2, ARO-HSD, ARO-HIF2, AMG 890, ARO-JNJ1, ARO-JNJ2 and AR …
  • Group Five Ltd (GRF):企業の財務・戦略的SWOT分析
    Group Five Ltd (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sumitomo Rubber Industries Ltd (5110):企業の財務・戦略的SWOT分析
    Sumitomo Rubber Industries Ltd (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Natural Beauty Bio-Technology Ltd.:戦略・SWOT・企業財務分析
    Natural Beauty Bio-Technology Ltd. - Strategy, SWOT and Corporate Finance Report Summary Natural Beauty Bio-Technology Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Ontario Power Generation Inc:企業の戦略的SWOT分析
    Ontario Power Generation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Alcazar Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Alcazar Energy Ltd (Alcazar Energy) is a renewable energy company which develops and produces power generation projects with focus on solar photovoltaic (PV) and onshore wind technologies. The company specializes in origination, development, structuring, acquisition and operation of renewabl …
  • Computershare Limited (CPU):企業の財務・戦略的SWOT分析
    Computershare Limited (CPU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • BioTime Inc (BTX)-医療機器分野:企業M&A・提携分析
    Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also develo …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務情報
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hoya Corp (7741):医療機器:M&Aディール及び事業提携情報
    Summary Hoya Corp (Hoya) is a global med-tech company that manufactures and sells precision devices and instruments built on its advanced optics technologies. Principal products include eyeglass and contact lenses, medical endoscopes, laparoscopic surgical instruments, intraocular lenses, orthopedic …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Hub Power Co Ltd (HUBC):企業の財務・戦略的SWOT分析
    The Hub Power Co Ltd (HUBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sistema JSFC:企業の戦略・SWOT・財務分析
    Sistema JSFC - Strategy, SWOT and Corporate Finance Report Summary Sistema JSFC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆